Ixazomib Has Not Shown The Cardiotoxicity of Injectable Proteasome Inhibitors

Frederic Reu, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic discusses how Ixazomib Has Not Shown The Cardiotoxicity of Injectable Proteasome Inhibitors